Gian-Marco Rinaldi Diaz de la Cruz

Gian-Marco Rinaldi Diaz de la Cruz

Direktor/Vorstandsmitglied bei NLS PHARMACEUTICS AG

Vermögen: 37 890 $ am 31.05.2024

51 Jahre
Consumer Services
Health Technology
Miscellaneous

Ursprung des Netzwerks ersten Grades von Gian-Marco Rinaldi Diaz de la Cruz

EinheitArt der EinheitIndustrie
Clariden Leu AG
24
Extinct Regional Banks 24
Public Company Pharmaceuticals: Major 17
3
Private Company Investment Trusts/Mutual Funds 3

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Gian-Marco Rinaldi Diaz de la Cruz

UnternehmenSektorVerknüpfte PersonenHauptposition
Chemicals: Agricultural

Carlos R. Camozzi

Corporate Officer/Principal

MORGAN STANLEY Investment Managers

Audrey Greenberg

Corporate Officer/Principal

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

UBS Investment Managers

Eric Henry Bernhardt

Richard O. Ebner

Corporate Officer/Principal

Director/Board Member

Investment Managers

Audrey Greenberg

Director of Finance/CFO

Investment Managers

Nathalie Flury

Scilla Huang Sun

Portfolio Manager-Equities

Head-Equity Investments

Investment Managers

Erich Pfister

Head of Private Banking

Investment Managers

Eric Henry Bernhardt

Scilla Huang Sun

Beat Wittmann

Corporate Officer/Principal

Head-Equity Investments

President

Investment Managers

Nathalie Flury

Stefan K. Kraeuchi

Irene Beatrice Püttner

Alfonso Gomez Velasco

Sascha Braun

Christian Bruns

Hilary Paul

Martin Schlatter

Corporate Officer/Principal

Chief Investment Officer

Portfolio Manager-Equities

Portfolio Manager-Equities

Portfolio Manager-Equities

Portfolio Manager-Fixed Income

Portfolio Manager-Fixed Income

Portfolio Manager-Equities

Investment Managers

Eric Henry Bernhardt

Director of Research - Equity

Investment Managers

Sandro Rosa

Erich Pfister

Analyst-Equity

Head of Private Banking

Miscellaneous Commercial Services

Audrey Greenberg

Corporate Officer/Principal

Investment Managers

Erich Pfister

Chief Executive Officer

Pharmaceuticals: Major

Silvia Panigone

Director/Board Member

Medical Specialties

Silvia Panigone

Director/Board Member

University of Basel College/University

Nathalie Flury

Myoung-Ok Kwon

Carlos R. Camozzi

Ronald Hafner

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Masters Business Admin

University of Milan College/University

Silvia Panigone

Undergraduate Degree

Universidad de Buenos Aires College/University

Carlos R. Camozzi

Doctorate Degree

Investment Managers

Erich Pfister

Chief Executive Officer

Investment Managers

Erich Pfister

Chief Executive Officer

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

Investment Managers

Matthias Müller

Corporate Officer/Principal

Investment Managers

Audrey Greenberg

Founder

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

Roche Corp.

Carlos R. Camozzi

Corporate Officer/Principal

Investment Managers

Christian Bruns

Portfolio Manager-Equities

ORPHAZYME A/S Pharmaceuticals: Major

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Fondazione Irccs Istituto Nazionale Dei Tumori College/University

Silvia Panigone

Doctorate Degree

Investment Managers

Audrey Greenberg

Private Equity Investor

UNIQURE N.V. Biotechnology

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

King of Prussia District

Audrey Greenberg

Director/Board Member

SDA Bocconi School of Management College/University

Silvia Panigone

Graduate Degree

Pharmaceuticals: Major

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

Finance/Rental/Leasing

Audrey Greenberg

Director of Finance/CFO

Household/Personal Care

Carlos R. Camozzi

Chief Tech/Sci/R&D Officer

Medical Specialties

Audrey Greenberg

Director/Board Member

Investment Managers

Christian Bruns

Chief Investment Officer

Miscellaneous Commercial Services

Audrey Greenberg

Director/Board Member

Healthcapital SA

Silvia Panigone

Chief Investment Officer

Investment Managers

Holger G. Demuth

Director/Board Member

Adya Consulting Sagl

Silvia Panigone

Chief Executive Officer

Philadelphia Alliance For Capital & Technologies

Audrey Greenberg

Director/Board Member

Break Into The Boardroom

Audrey Greenberg

Director/Board Member

Pharmaceuticals: Major

Carlos R. Camozzi

Corporate Officer/Principal

Internet Software/Services

Silvia Panigone

Corporate Officer/Principal

Statistik

International

Schweiz 22
Vereinigte Staaten 18
Vereinigtes Königreich 4
Italien 4
Niederlande 3

Sektoral

Finance 21
Health Technology 10
Commercial Services 6
Consumer Services 6
Process Industries 2

Operativ

Director/Board Member 56
Corporate Officer/Principal 48
Portfolio Manager-Equities 32
Chairman 24
Chief Executive Officer 20